Main > INFECTIOUS DISEASES > Virus Infectious Diseases+ > HIV Infection (AIDS) > Treatment > Co: USA. G. Emtricitabine+Rilp+TAF

---

Co: USA. G. Emtricitabine+Rilp+TAF's subsections
(*) EU Approval Date: 2016. 06.23.
(*) USA Approval Date: 2016. 03.01.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>ORANGE Book Only
Patent>Total USA No.: 3
TAF: Tenofovir AlaFenamide
TradeMark
TradeMark Web-Site

Co: USA. G. Emtricitabine+Rilp+TAF's products
This section has no products